You will be shown inclusion or exclusion criteria for a clinical trial. Given these criteria, your task is to extract all unique entities of the following types: ["Observation", "Condition", "Procedure", "Drug", "Temporal", "Multiplier", "Qualifier", "Negation", "ReferencePoint", "Scope", "Value", "Mood", "Device", "Visit", "Measurement", "Person"].

Please return the output as a JSON object of the format: {"Condition" : ["breast cancer", ...], "Device" : ["ports", ...], "Drug" : ["Atenolol", ...], "Measurement" : ["blood pressure", ...], "Mood" : ["suspected", ...], "Multiplier" : ["more than two", ...], "Negation" : ["no", ...], "Observation" : ["history", ...], "Person" : ["male", ...], "Procedure" : ["surgery", ...], "Qualifier" : ["severe", ...], "ReferencePoint" : ["enrollment", ...], "Scope" : ["infection", ...], "Temporal" : ["one day", ...], "Value" : ["50%", ...], "Visit" : ["ICU", ...]}. The keys should be entity types and values should be lists of extracted entities belonging to the corresponding type. If you cannot find entities belonging to a specific type, the value should be [].

Only output the JSON object and do not include any additional text.

Abstract:

Previous or concurrent malignancy, except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or any other cancer for which the patient has been previously treated and the lifetime recurrence risk is less than 30%
Inflammatory bowel disease that is uncontrolled or on active treatment (Crohn's disease, ulcerative colitis)
Diarrhea, grade 1 or greater by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE, version [v] 4.0)
Neuropathy, grade 2 or greater by NCI-CTCAE, v 4.0
Serious underlying medical or psychiatric illnesses that would, in the opinion of the treating physician, substantially increase the risk for complications related to treatment
Active uncontrolled bleeding
Pregnancy or breastfeeding
Major surgery within 4 weeks
Patients with any polymorphism in UGT1A1 other than *1 or *28 (e.g, *6) will be allowed and treated as in the *28/*28 dosing group
{"Condition": ["Diarrhea", "malignancy", "ulcerative colitis", "bleeding", "squamous cell skin cancer", "Crohn\u0027s disease", "cervical cancer", "basal cell skin cancer", "Neuropathy", "Inflammatory bowel disease"], "Device": [], "Drug": [], "Measurement": ["NCI-CTCAE, v 4.0", "NCI-CTCAE, version [v] 4.0", "National Cancer Institute Common Terminology Criteria for Adverse Events"], "Mood": [], "Multiplier": [], "Negation": ["except"], "Observation": [], "Person": [], "Procedure": ["treatment", "Major surgery"], "Qualifier": ["Previous", "adequately treated", "in situ", "Active", "concurrent", "uncontrolled"], "ReferencePoint": [], "Scope": ["adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer", "Crohn\u0027s disease, ulcerative colitis", "basal cell or squamous cell skin cancer", "Inflammatory bowel disease that is uncontrolled or on active treatment", "Previous or concurrent", "uncontrolled or on active treatment"], "Temporal": ["within 4 weeks"], "Value": ["grade 1 or greater", "grade 2 or greater"], "Visit": []}